Time to full publication of studies of anticancer drugs for breast cancer, and the potential for publication bias
Harris, Petra, Takeda, Andrea, Loveman, Emma and Hartwell, Debbie (2010) Time to full publication of studies of anticancer drugs for breast cancer, and the potential for publication bias. International Journal of Technology Assessment in Health Care, 26, (1), 110-116. (doi:10.1017/S0266462309990778). (PMID:20059788).
Full text not available from this repository.
Whereas delays in publication appear reasonable over a period of months, many were not published in full over a period of years and others would appear to be unlikely to ever be published. Further research should investigate the impact of publication delays on the availability of new drug treatments in clinical practice
|Digital Object Identifier (DOI):||doi:10.1017/S0266462309990778|
|Subjects:||R Medicine > RC Internal medicine
R Medicine > RC Internal medicine > RC0254 Neoplasms. Tumors. Oncology (including Cancer)
R Medicine > RM Therapeutics. Pharmacology
|Divisions:||Faculty of Medicine
|Date Deposited:||27 Oct 2011 08:01|
|Last Modified:||31 Mar 2016 13:45|
|RDF:||RDF+N-Triples, RDF+N3, RDF+XML, Browse.|
Actions (login required)